Results 191 to 200 of about 9,912 (208)

Efficacy and tolerability of vildagliptin as an add-on to glimepiride in Japanese patients with Type 2 diabetes mellitus

Diabetes Research and Clinical Practice, 2010
Yukiko Onishi
exaly  

Measurements of Islet Function and Glucose Metabolism with the Dipeptidyl Peptidase 4 Inhibitor Vildagliptin in Patients with Type 2 Diabetes

Journal of Clinical Endocrinology and Metabolism, 2008
Zofia Radikova, Frederico G S Toledo, Chiara Dalla Man   +2 more
exaly  

Effects of vildagliptin on glucose control in patients with type 2 diabetes inadequately controlled with a sulphonylurea*

Diabetes, Obesity and Metabolism, 2008
exaly  

Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes

Diabetologia, 2006
exaly  

Vildagliptin dose-dependently improves glycemic control in Japanese patients with type 2 diabetes mellitus

Diabetes Research and Clinical Practice, 2009
exaly  

Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes

Diabetologia, 2007
exaly  

Vildagliptin add‐on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2‐year study

Diabetes, Obesity and Metabolism, 2010
exaly  

Vildagliptin

Reactions Weekly, 2015
openaire   +1 more source

Improved glycaemic control with vildagliptin added to insulin, with or without metformin, in patients with type 2 diabetes mellitus

Diabetes, Obesity and Metabolism, 2013
exaly  

Vildagliptin

Reactions Weekly
openaire   +1 more source